Literature DB >> 8597561

Population analysis of protection by HLA-DR and DQ genes from insulin-dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls.

I Kockum1, C B Sanjeevi, S Eastman, M Landin-Olsson, G Dahlquist, A Lernmark.   

Abstract

A negative association between insulin-dependent diabetes mellitus (IDDM) and HLA-DR, DQA1 or DQB1 was found in a large population-based investigation of childhood-onset patients (more than 420 patients) and controls (more than 340 controls) from Sweden. The relative risk was decreased for several haplotypes that were negatively associated with IDDM: DR15-DQA1*0102-DQB1*0602, DR7-DQA1*0201-DQB1*0303, DR14-DQA1*0101-DQB1*0503, DR11-DQA1*0501-DQB1*0301, DR13-DQA1*0103-DQB1*0603 and DR4-DQA1*0301-DQB1*0301. In a relative predispositional effect (RPE) analysis, however, only the DR15-DQA1*0102-DQB1*0602 haplotype was significantly decreased, which suggests that the major protective effect for IDDM is carried by this haplotype. This was supported by the observation that all genotypes which were negatively associated with IDDM, except DR7/13, included at least one allele from the DR15-DQA1*0102-DQB1*0602 haplotype. Relative predispositional effect (RPE) analysis of genotypes showed further that the DR15-DQA1*0102-DQB1*0602 haplotype was also negatively associated with IDDM when combined with any other haplotype, whether negatively or positively associated with IDDM. This supports previous suggestions that DR15-DQA1*0102-DQB1*0602 acts dominantly. However, both the stratification and the predispositional allele test failed to distinguish the negative association between IDDM and DR15 from that of DQB1*0602. On the other hand, these tests indicated that DQA1*0102 was not likely to explain the negative association between IDDM and the DR15-DQA1*0102-DQB1*0602 haplotype. We conclude that the major protective effect for IDDM in the population of Swedish children is conferred by the DR15-DQA1*0102-DQB1*0602 haplotype in a dominant fashion, the DQB1*0602 allele being the allele most likely to be responsible for the protective effect of this haplotype, although an effect of the DR15 allele could not be excluded.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8597561     DOI: 10.1111/j.1744-313x.1995.tb00282.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  5 in total

1.  Diabetes-associated HLA genotypes affect birthweight in the general population.

Authors:  H E Larsson; K Lynch; B Lernmark; A Nilsson; G Hansson; P Almgren; A Lernmark; S-A Ivarsson
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

2.  Approaches in type 1 diabetes research: A status report.

Authors:  Oindrila Raha; Subhankar Chowdhury; Samir Dasgupta; P Raychaudhuri; B N Sarkar; P Veer Raju; V R Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

3.  Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden.

Authors:  A Carlsson; I Kockum; B Lindblad; L Engleson; A Nilsson; G Forsander; A-K Karlsson; A Kernell; J Ludvigsson; C Marcus; I Zachrisson; S-A Ivarsson; A Lernmark
Journal:  Int J Obes (Lond)       Date:  2011-06-28       Impact factor: 5.095

4.  Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression.

Authors:  Ying Jin; Genevieve H L Roberts; Tracey M Ferrara; Songtao Ben; Nanja van Geel; Albert Wolkerstorfer; Khaled Ezzedine; Janet Siebert; Charles P Neff; Brent E Palmer; Stephanie A Santorico; Richard A Spritz
Journal:  Nat Commun       Date:  2019-01-23       Impact factor: 14.919

5.  A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes.

Authors:  Christian S Parry; Bernard R Brooks
Journal:  Biol Direct       Date:  2008-10-14       Impact factor: 4.540

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.